Skip to content
healthcare.dev

Synjardy

NDC 0597-0180, empagliflozin and metformin hydrochloride, tablet, from Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC
0597-0180
Status
Listed
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206111
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMPAGLIFLOZIN12.5 mg/1
  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0597-0180-1800597018018180 TABLET in 1 BOTTLE (0597-0180-18)
0597-0180-600059701806060 TABLET in 1 BOTTLE (0597-0180-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0fdd0255-0055-65f3-b2c0-db8fbb87beae
  • NADAC price for package 00597018018

    GET /v1/drugs/nadac/00597018018
  • NADAC price for package 00597018060

    GET /v1/drugs/nadac/00597018060

Use it

Look up 0597-0180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0597-0180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.